Wound reepithelialization activates a growth factor-responsive enhancer in migrating keratinocytes.
Wound reepithelialization and keratinocyte migration require strictly ordered gene expression, which is assumed to be initiated by locally released mitogens and exposure of the cells to different matrix components. The mechanisms triggering gene expression specifically during reepithelialization are poorly understood. The far upstream AP-1-driven, FGF-inducible response element (FiRE) of the syndecan-1 gene was activated during cutaneous wound healing in transgenic mice. FiRE was induced selectively in migrating but not in proliferating keratinocytes at the wound edge. The activation was initiated at the start of the cell migration, was persistent throughout the merging and stratification phases, and was terminated after completion of reepithelialization. Although FiRE has been found within the gene of syndecan-1, the proximal promoter of syndecan-1 was not required for activation of FiRE in the migrating keratinocytes. The wounding induced activation was inhibited by blocking cell surface growth factor receptors with suramin. However, the activation of FiRE in resting skin required simultaneous growth factor- and stress-induced signals, but could also be elicited by the phosphatase inhibitor, okadaic acid. The activation by both wounding and chemical stimuli was blocked by inhibiting extracellular regulated kinase and p38 MAP kinases, suggesting the involvement of at least two parallel signal transduction pathways in wounding induced gene activation. As FiRE shows specificity for migrating keratinocytes only, it can be a useful tool for future wound healing studies and for targeting genes to injured tissues.
Turku Centre for Biotechnology, University of Turku, BioCity, Finland.
P
P
Jaakkola
S
S
Kontusaari
T
T
Kauppi
A
A
Määtä
M
M
Jalkanen
D000818:Animals; D000841:Anisomycin / Q000494:pharmacology; D017871:Calcium-Calmodulin-Dependent Protein Kinases / Q000037:antagonists & inhibitors; D002455:Cell Division; D002460:Cell Line; D002465:Cell Movement; D004742:Enhancer Elements, Genetic; D004791:Enzyme Inhibitors / Q000494:pharmacology; D004848:Epithelium / Q000502:physiology; D005346:Fibroblast Growth Factors / Q000502:physiology*; D005419:Flavonoids / Q000494:pharmacology; D005786:Gene Expression Regulation; D019833:Genistein / Q000494:pharmacology; D007093:Imidazoles / Q000494:pharmacology; D066298:In Vitro Techniques; D015603:Keratinocytes / Q000378:metabolism / Q000502:physiology*; D008562:Membrane Glycoproteins / Q000235:genetics; D051379:Mice; D008822:Mice, Transgenic; D019950:Mitogen-Activated Protein Kinase 1; D048052:Mitogen-Activated Protein Kinase 3; D020928:Mitogen-Activated Protein Kinases; D011401:Promoter Regions, Genetic; D011509:Proteoglycans / Q000235:genetics; D011725:Pyridines / Q000494:pharmacology; D017978:Receptors, Growth Factor / Q000037:antagonists & inhibitors; D012879:Skin Physiological Phenomena; D013498:Suramin / Q000494:pharmacology; D053668:Syndecan-1; D053667:Syndecans; D015533:Transcriptional Activation; D014945:Wound Healing / Q000235:genetics / Q000502:physiology*; D048051:p38 Mitogen-Activated Protein Kinases
D004791:Enzyme Inhibitors; D005419:Flavonoids; D007093:Imidazoles; D008562:Membrane Glycoproteins; D011509:Proteoglycans; D011725:Pyridines; D017978:Receptors, Growth Factor; C508242:Sdc1 protein, mouse; D053668:Syndecan-1; D053667:Syndecans; D013498:Suramin; D005346:Fibroblast Growth Factors; D000841:Anisomycin; D019833:Genistein; D017871:Calcium-Calmodulin-Dependent Protein Kinases; D019950:Mitogen-Activated Protein Kinase 1; D048052:Mitogen-Activated Protein Kinase 3; D020928:Mitogen-Activated Protein Kinases; D048051:p38 Mitogen-Activated Protein Kinases; C093642:SB 203580; C093973:2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one